Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of selling price gouging, pointing out the stark contrast between U.S. price ranges and people in Europe and copyright. At the center of the weigh